Stock Quote
NASDAQBSTC

BioSpecifics Technologies Corp. to Host Conference Call to Report First Quarter 2011 Financial Results

PR Newswire
LYNBROOK, N.Y.
May 4, 2011

BioSpecifics Technologies Corp. to Host Conference Call to Report First Quarter 2011 Financial Results

PR Newswire

LYNBROOK, N.Y., May 4, 2011 /PRNewswire/ -- BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company developing first in class collagenase-based products, announced today that it will host a conference call and live audio webcast at 4:30pm EDT on Tuesday, May 10, 2011 to report its first quarter 2011 financial results and recent corporate highlights.

The Company will be hosting a conference call to discuss these financial results and provide a corporate update. In order to participate, please dial 800-860-2442 (domestic) or 412-858-4600 (international). The live webcast can be accessed under "Calendar of Events" in the Investor Relations section of the Company's website at www.biospecifics.com, or you may use the link: www.videonewswire.com/event.asp?id=79356.

A replay of the call will be available one hour after the conference ends May 10, 2011 until 9:00am EDT on May 20, 2011. To access the replay, please dial 877-344-7529 (domestic) or 412-317-0088 (international) and reference the access code 450795. The archived webcast will be available for 90 days in the Investor Relations section of the BioSpecifics' website at www.biospecifics.com.

About BioSpecifics Technologies Corp.

BioSpecifics Technologies Corp. is a biopharmaceutical company that has developed injectable collagenase for twelve clinical indications, three of which include: Dupuytren's contracture, Peyronie's disease, and frozen shoulder (adhesive capsulitis). Its strategic partner Auxilium markets XIAFLEX® in the U.S. for the treatment of Dupuytren's contracture. Pfizer, Inc. is responsible for marketing XIAPEX® in Europe and has announced European regulatory approval and the first commercial sale in the United Kingdom. Asahi Kasei Pharma Corporation is responsible for marketing XIAFLEX® in Japan. More information about BioSpecifics may be found on its website at www.biospecifics.com.  

SOURCE BioSpecifics Technologies Corp.